1. 13 Efficacy on individualized starting dose (ISD) and fixed starting dose (FSD) of niraparib per investigator-assessment (IA) in newly diagnosed advanced ovarian cancer (OC). (13th November 2020) Authors: Graybill, W; Mirza, M; González-Martin, A; O'Malley, D; Gaba, L; Yap, OWS; Guerra, E; Rose, PG; Baurain, J; Ghamande, S; Denys, H; Prendergast, E; Pisano, C; Follana, P; Braicu, EI; Calvert, PM; Korach, J; Li, Y; Gupta, D; Monk, BJ Journal: International journal of gynecological cancer Issue: Volume 30(2020)Supplement 3 Page Start: A10 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗